Discovering Clinical Study Experiences of Patients With Pulmonary Hypertension
Part of paid clinical trials in San Francisco, California.
- Sponsor
- Power Life Sciences Inc.
- Study ID
- NCT05918458
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Pulmonary Hypertension
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
Taking part in medical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This study will admit a wide range of data on the clinical trial experience of pulmonary hypertension patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future pulmonary hypertension patients.
Key Dates
- Start date
- Jul 31, 2024
- Status verified
- Jun 2023
- Primary completion
- Jul 31, 2025
- Completion
- Jul 31, 2026
Study Design
- Enrollment
- 500 participants (estimated)
Primary Outcome Measure
Number of patients who decide to enroll in a pulmonary hypertension clinical research [ Time Frame: 3 months ]
Central Contacts
- Michael B Gill415-900-4227
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Power Life Sciences | San Francisco | California | 94107 | - |
Find similar trials in San Francisco, CA
Related Studies
- Investigation of Dysynchrony in Patients With Pulmonary HypertensionEnrolling By Invitation · Stanford University · Stanford, California
- MRI and Computational Simulation Cardiology StudyEnrolling By Invitation · Stanford University · Palo Alto, California
- Metformin for Pulmonary Hypertension HFpEFPHASE2 · Recruiting · University of California, San Francisco · San Francisco, California
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona